LON:DCTA Directa Plus (DCTA) Share Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DCTA Stock Alerts GBX 19.20 +0.50 (+2.67%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range 18▼ 2050-Day Range 17▼ 2052-Week Range 16▼ 79Volume86,146 shsAverage Volume55,823 shsMarket Capitalization£12.68 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Directa Plus alerts: Email Address Ad Behind the MarketsBREAKING – Pentagon to Spend $20 Billion on “Distributed AI”BREAKING - Pentagon to Spend $20 Billion on "Distributed AI" The U.S. Space Force calls it a "game changer." And one tiny firm is poised to win the contract to build it.Discover the name and ticker of this $2 stock here >>> About Directa Plus Stock (LON:DCTA)Directa Plus Plc manufactures and sells graphene-based products for industrial and commercial applications in Italy and internationally. It operates through Textile, Environmental, and Others segments. The company offers its products under the G+ brand name. Its products are used in environment, textile, composites, elastomers, battery, paints, and tires applications. Directa Plus Plc was incorporated in 2003 and is based in Lomazzo, Italy.Read More DCTA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DCTA Stock News HeadlinesMay 7, 2024 | msn.comDCTA organizes 'walk-ins' to call on district to pay according to contract agreementsMay 7, 2024 | msn.comDenver Public Schools teachers host ‘walk-ins’ calling on district to uphold financial agreementMay 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.May 4, 2024 | americanbankingnews.comDirecta Plus (LON:DCTA) Stock Price Passes Below 50 Day Moving Average of $18.77April 12, 2024 | lse.co.ukDirecta Plus sustainable tarmac fitted for Emilia-Romagna Grand PrixSeptember 29, 2023 | nz.finance.yahoo.comWall St. ends higher as investors digest economic dataSeptember 29, 2023 | nz.finance.yahoo.comWall St. ends higher as investors digest economic dataSeptember 29, 2023 | finance.yahoo.comDirecta Plus First Half 2023 Earnings: €0.028 loss per share (vs €0.034 loss in 1H 2022)May 8, 2024 | Smallcaps Daily (Ad)The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.September 27, 2023 | marketwatch.comDirecta Plus Pretax Loss Narrowed on Improved Margins, Contract WinsAugust 19, 2023 | finance.yahoo.comDirecta Plus Plc's (LON:DCTA) P/S Still Appears To Be ReasonableJuly 12, 2023 | finance.yahoo.comWesthaven Provides an Update on Its Skoonka North Program: Assays 1,720 ppb Gold in Silt SampleMay 29, 2023 | finance.yahoo.comIs It Time To Consider Buying Directa Plus Plc (LON:DCTA)?May 10, 2023 | proactiveinvestors.comDirecta Plus wins new workwear order from partner GrassiMarch 21, 2023 | proactiveinvestors.comDirecta Plus granted Italian patentFebruary 27, 2023 | marketwatch.comDirecta Plus Expects 2022 Revenue to Be Not Less Than EUR10.8 MlnJanuary 3, 2023 | finance.yahoo.comInvestors in Directa Plus (LON:DCTA) have made a favorable return of 97% over the past five yearsDecember 21, 2022 | proactiveinvestors.comDirecta Plus signs European distribution contract for Grafyshield G+December 2, 2022 | proactiveinvestors.comDirecta Plus takes revenue hit in 2022 due to supply chain issues but enters 2023 with record order bookNovember 29, 2022 | proactiveinvestors.comDirecta Plus wins grant to develop new G+ technologyNovember 21, 2022 | proactiveinvestors.comDirecta Plus names new non-executive directorOctober 28, 2022 | proactiveinvestors.comDirecta Plus signs first contract in Latin AmericaOctober 21, 2022 | proactiveinvestors.comDirecta Plus to supply graphene for 250km Italian motorway road surfacing contractOctober 17, 2022 | proactiveinvestors.comDirecta Plus appoints former US general Wesley Clark as independent directorOctober 17, 2022 | proactiveinvestors.comDirecta Plus appoints former US general Wesley Clark as an independent directorSeptember 29, 2022 | proactiveinvestors.comDirecta Plus says ‘significant’ revenue growth to continue as interim sales jump 39%September 29, 2022 | proactiveinvestors.comDirecta Plus sees ‘significant’ revenue growth continuing after strong top-line performance in first halfSee More Headlines Receive DCTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Directa Plus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolLON:DCTA CUSIPN/A CIKN/A Webwww.directa-plus.com Phone39 02 36 71 44 00FaxN/AEmployees191Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-4,440,000.00 Net Margins-44.70% Pretax MarginN/A Return on Equity-43.91% Return on Assets-18.53% Debt Debt-to-Equity Ratio31.50 Current Ratio3.46 Quick Ratio4.88 Sales & Book Value Annual Sales£9.94 million Price / Sales1.22 Cash FlowGBX 2.45 per share Price / Cash Flow7.51 Book ValueGBX 11 per share Price / Book1.67Miscellaneous Outstanding Shares66,060,000Free FloatN/AMarket Cap£12.16 million OptionableNot Optionable Beta0.63 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Giulio Giuseppe Cesareo (Age 68)Founder, CEO & Executive Director Comp: $347.05kMr. Giorgio BonfantiCompany Secretary, CFO & Executive DirectorMr. Razvan PopescuChief Operating OfficerDr. Laura Giorgia Rizzi Ph.D.Chief Technical OfficerMs. Alessandra BambiniSales & Marketing DirectorKey CompetitorsHaydale Graphene IndustriesLON:HAYDHardideLON:HDDWilmcote Holdings plc (WCH.L)LON:WCHItaconixLON:ITXIofinaLON:IOFView All Competitors DCTA Stock Analysis - Frequently Asked Questions How have DCTA shares performed in 2024? Directa Plus' stock was trading at GBX 24.50 on January 1st, 2024. Since then, DCTA shares have decreased by 21.6% and is now trading at GBX 19.20. View the best growth stocks for 2024 here. What other stocks do shareholders of Directa Plus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Directa Plus investors own include Indivior (INDV), Advanced Accelerator Applications (AAAP), Editas Medicine (EDIT), MGT Capital Investments (MGTI), Biglari (BH), Bigblu Broadband (BBB), Futura Medical (FUM), Lakehouse (LAKE), Adobe (ADBE) and Danone (BN). How do I buy shares of Directa Plus? Shares of DCTA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DCTA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Directa Plus Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.